Published by Benjamin Chiou on 18th May 2026
(Sharecast News) - Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-quarter earnings season.
URL: http://www.digitallook.com/dl/news/story/35939561/...